Blood Pressure Control Goals in Elderly
Patients with Hypertension：Evidence from Latest Clinical Studies

doi:10.12114/j.issn.1007-9572.2022.01.303

Chinese General Practice ›› 2022, Vol. 25 ›› Issue (11): 1305-1308.DOI: 10.12114/j.issn.1007-9572.2022.01.303

Special Issue: 老年人群健康最新文章合辑；高血压最新文章合辑；老年问题最新文章合辑

• Clinical Decision Support • Previous Articles Next Articles

Blood Pressure Control Goals in Elderly Patients with Hypertension：Evidence from Latest Clinical Studies

1.Department of Geriatric Cardiology，Hebei General Hospital，Shijiazhuang 050051，China
2.Graduate School of Hebei Medical University，Shijiazhuang 050000，China
*Corresponding author：GUO Yifang，Professor；E-mail：guoyifang@hotmail.com

Received:2021-11-18 Revised:2022-02-23 Published:2022-04-15 Online:2022-03-28

从最新临床研究证据看老年高血压患者的血压控制目标

¹050051　河北省石家庄市，河北省人民医院老年心血管内科
²050000　河北省石家庄市，河北医科大学研究生院

通讯作者: 郭艺芳
基金资助:
河北省重点研发计划(19277787D);河北省创新能力提升计划(199776249D)

Abstract

Abstract:

Due to the lack of relevant research evidence, the optimal blood pressure target in elderly hypertensive patients has been controversial for a long time. Many scholars believe that the elderly have poor tolerance to antihypertensive treatment, so their blood pressure control goal should bemore relaxed. However, the latest research evidence published in recent years shows that there may be more benefits from controlling systolic blood pressure in older adults to <130 mmHg. It is expected that these new research conclusions will have an important impact on the revision of guidelines in the future.

Key words: Hypertension, Guidelines, Antihypertensive therapy, Aged

摘要：

由于相关研究证据较少，长期以来老年高血压患者的血压控制目标一直存在争议。很多学者认为，老年高血压患者对于降压治疗的耐受性较差，因而其血压控制目标应该更宽松。但近年来发表的最新研究证据表明，将老年高血压患者收缩压控制在<130 mm Hg（1 mm Hg=0.133 kPa）可以更多获益。预期这些新研究结论将会对未来国内外指南的修订产生重要影响。

关键词: 高血压, 指南, 降压治疗, 老年人

CLC Number:

R544.1

LIU Kaixuan, GUO Yifang.

Blood Pressure Control Goals in Elderly Patients with Hypertension：Evidence from Latest Clinical Studies [J]. Chinese General Practice, 2022, 25(11): 1305-1308.

刘凯旋,郭艺芳. 从最新临床研究证据看老年高血压患者的血压控制目标[J]. 中国全科医学, 2022, 25(11): 1305-1308. DOI: 10.12114/j.issn.1007-9572.2022.01.303.

References 13

[1]	李苏宁，陈祚，王增武，等. 我国老年人高血压现状分析[J]. 中华高血压杂志，2019，27（2）：140-148. DOI：10.16439/j.cnki.1673-7245.2019.02.010.
[2]	中国高血压防治指南修订委员会，高血压联盟（中国），中华医学会心血管病学分会，等. 中国高血压防治指南（2018年修订版）[J]. 中国心血管杂志，2019，24（1）：24-56. DOI：10.3969/j.issn.1007-5410.2019.01.002.
[3]	WHELTON P K，CAREY R M，ARONOW W S，et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention，detection，evaluation，and management of high blood pressure in adults：a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines [J]. Journal of the American College of Cardiology，2018，71（19）：e127-248. DOI：10.1016/j.jacc.2017.11.006.
[4]	LEUNG A A，NERENBERG K，DASKALOPOULOU S S，et al. Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement，diagnosis，assessment of risk，prevention，and treatment of hypertension[J]. Can J Cardiol，2016，32（5）：569-588. DOI：10.1016/j.cjca.2016.02.066.
[5]	VISSEREN F L J，MACH F，SMULDERS Y M，et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice[J]. Eur Heart J，2021，42（34）：3227-3337. DOI：10.1093/eurheartj/ehab484.
[6]	Sprint Research Group，WRIGHT J T Jr，WILLIAMSON J D，et al. A randomized trial of intensive versus standard blood-pressure control[J]. N Engl J Med，2015，373（22）：2103-2116. DOI：10.1056/NEJMoa1511939.
[7]	Blood Pressure Lowering Treatment Trialists' Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death：an individual participant-level data meta-analysis[J]. Lancet，2021，398（10305）：1053-1064.
[8]	ZHANG W L，ZHANG S Y，DENG Y，et al. Trial of intensive blood-pressure control in older patients with hypertension[J]. N Engl J Med，2021，385（14）：1268-1279. DOI：10.1056/NEJMoa2111437.
[9]	WILLIAMS B，MANCIA G，SPIERING W，et al. 2018 ESC/ESH guidelines for the management of arterial hypertension[J]. Eur Heart J，2018，39（33）：3021-3104.
[10]	ARVANITIS M，QI G H，BHATT D L，et al. Linear and nonlinear mendelian randomization analyses of the association between diastolic blood pressure and cardiovascular events：the J-curve revisited[J]. Circulation，2021，143（9）：895-906.
[11]	JURASCHEK S P，HU J R，CLUETT J L，et al. Effects of intensive blood pressure treatment on orthostatic hypotension：a systematic review and individual participant-based meta-analysis[J]. Ann Intern Med，2021，174（1）：58-68.
[12]	LIP S，TAN L E，JEEMON P，et al. Diastolic blood pressure J-curve phenomenon in a tertiary-care hypertension clinic[J]. Hypertension，2019，74（4）：767-775. DOI：10.1161/HYPERTENSIONAHA.119.12787.
[13]	CARDOSO C R L，SALLES G F. Associations between achieved ambulatory blood pressures and its changes with adverse outcomes in resistant hypertension：was there a J-curve for ambulatory blood pressures? [J]. Hypertension，2021，77（6）：1895-1905. DOI：10.1161/HYPERTENSIONAHA.121.17200.

[1]	WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun. Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules [J]. Chinese General Practice, 2025, 28(30): 3787-3795.
[2]	BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang. Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China [J]. Chinese General Practice, 2025, 28(30): 3741-3746.
[3]	XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822.
[4]	QIN Bangguo, SUN Jin, LI Man, QIU Jiaojiao, CHENG Bokai, ZHU Ping, WANG Shuxia. Relationship between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Left Ventricular Hypertrophy in a Community-based Hypertensive Population [J]. Chinese General Practice, 2025, 28(30): 3753-3760.
[5]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[6]	HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258.
[7]	YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143.
[8]	TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua. Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3089-3095.
[9]	YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004.
[10]	YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058.
[11]	LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999.
[12]	WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan. Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension [J]. Chinese General Practice, 2025, 28(24): 2972-2978.
[13]	HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971.
[14]	CHEN Youlan, LAN Yanqi, WU Ahua, ZHANG Haixia, HUANG Jiankang, GUO Zhinan. The Health Management Effect of Contracted Family Doctor Services under the Joint Management of Three Teachers in Xiamen City on Elderly Hypertensive Patients [J]. Chinese General Practice, 2025, 28(22): 2769-2775.
[15]	ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi. Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(22): 2776-2783.

Blood Pressure Control Goals in Elderly Patients with Hypertension：Evidence from Latest Clinical Studies

从最新临床研究证据看老年高血压患者的血压控制目标

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 13

Related Articles 15

Recommended Articles

Metrics

Comments